Skip to main content

Table 1 Demographics and clinical data of patients on drug initiation (n = 63) and with regard to initial Cpeak/MIC ratio and loading dose (D1 = 18 to 24 mg/kg; D2 = 25 to 30 mg/kg)

From: Therapeutic drug monitoring of amikacin in septic patients

 

All patients

(n= 63)

Cpeak/MIC ≥8

(n= 40)

Cpeak/MIC <8

(n= 23)

D1

(n= 39)

D2

(n= 24)

Female/Male, n

22 / 41

14 / 30

8 / 11

13 / 26

9 / 16

Age (years)

59 ± 16

58 ± 15

60 ± 18

59 ± 15

59 ± 18

IBW (kg)

65 ± 10

65 ± 9

64 ± 10

64 ± 10

66 ± 9

ABW (kg)

67 ± 12

68 ± 13

66 ± 12

67 ± 13

67 ± 10

APACHE II score

21 (19-25)

21 (19-24)

23 (18-27)

21 (15-31)

21 (12-27)

SOFA

10 (8-11)

10 (8-11)

9 (8-11)

10 (7-11)

9 (8-11)

Severe sepsis/septic shock, n

43 / 20

26 / 14

17 / 6

28 / 11

15 / 9

Mechanical ventilation, n (%)

63 (100)

40 (100)

23 (100)

39 (100)

24 (100)

Immunosuppression, n (%)

13 (21)

8 (20)

5 (22)

8 (21)

5 (21)

Concomitant nephrotoxic agents, n (%)

     

Vancomycin

4 (6)

3

1

3

1

Colistin

8 (13)

5

3

5

3

Amphotericin B

-

-

-

-

-

NSAIDs

24 (38)

15

9

14

10

Contrast medium

11 (17)

8

3

7

4

Diuretics

15 (24)

10

5

9

6

Others

1 (2)

1

-

1

-

Type of infection, n (%)

     

CR-BS

10 (16)

6

4

5

5

VAP

34 (54)

24

10

23

11

HAP

7 (11)

6

1

6

1

Peritonitis

6 (9)

3

3

3

3

Others

6 (9)

1

5

2

4

Temperature, °C

37.7 ± 1.0

37.9 ± 0.8

37.6 ± 1.1

37.7 ± 1.0

38.0 ± 0.7

White blood cells, n × 103/mm3

12.7 (8.5-16.7)

12.6 (8.4-19.3)

12.8 (8.8-15.9)

13.6 (8.8-17.1)

12.1 (8.1-20.1)

C-reactive protein, ng/mL

121 (69-166)

108 (60-159)

139 (102-196)*

113 (76-159)

132 (98-194)#

Procalcitonin, ng/mL

1.2 (0.5-5.9)

0.7 (0.3-4.6)

1.8 (1.1-6.8)*

0.7 (0.3-5.5)

2.0 (1.2-7.9)#

Hematocrit, %

27.9 (25.7-30)

28.8 (25.8-31.6)

27.0 (25.5-29.2)

28.0 (22.8-39)

26.7 (22.3-38.1)

Serum proteins, g/dL

4.9 ± 0.7

4.5 ± 0.6

5.0 ± 1.0

5.0 ± 0.8

4.9 ± 0.8

Albumin, g/dL

2.2 ± 0.5

2.1 ± 0.4

2.3 ± 0.5

2.3 ± 0.6

2.1 ± 0.3

Serum creatinine, mg/dL

1.1 ± 0.8

1.1 ± 0.8

1.1 ± 0.7

1.1 ± 0.9

1.0 ± 0.7

Creatinine clearance, mL/min

67 (50-118)

81 (52-108)

65 (45-130)

80 (40-108)

64 (50-143)

ICU stay, days

50 (18-65)

37 (14-77)

46 (11-58)

48 (24-68)

47 (17-66)

ICU mortality, n (%)

16 (25)

11 (27)

5 (22)

8 (21)

8 (33)

  1. Data are presented as counts (percentage), mean (± standard deviation (SD)) or median (interquartile range (IQR). *P <0.05 vs. Cpeak/MIC ≥8; #P<0.05 vs. D1. Cpeak, peak concentration; MIC, minimum inhibitory concentration; D1, loading dose 18 to 24 mg/kg; D2, loading dose 25 to 30 mg/kg; IBW, ideal body weight; ABW, adjusted body weight; APACHE, acute physiology and health evaluation; SOFA, sequential organ failure assessment; CR-BSI, catheter-related bloodstream infection; HAP, hospital-acquired pneumonia; VAP, ventilator-associated pneumonia.